🇺🇸·21h agoResearch
NCT07010120: A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- July 1, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
UNC Chapel Hill/5h ago
Carolina’s School of Data and Information Sciences launches
UNC Chapel Hill/5h ago
Collaboration is key for Carolina’s newest school
University of Alabama at Birmingham/5h ago
$10 million gift launches statewide effort to expand access to care in rural Alabama
NORD Rare Diseases/5h ago